What you should know:
1. Orthofix’s net sales for the quarter were basically flat year over year. The company reported $121.5 million in sales for the fourth quarter, a slight year-over-year increase from $121.1 million the same time last year. On the year, the company reported nearly $460 million in sales.
2. The company’s spine-related adjusted EBITDA was $22.7 million, the largest of its divisions. The company posted $4.7 million in corporate losses. Total adjusted EBITDA was $22.5 million.
3. Orthofix issued its 2020 projections, expecting net sales between $467 million and $477 million, and adjusted EBITDA between $65 million and $68 million.
5. For the first quarter of 2020, Orthofix expects to post net sales between $106 million and $109 million.
Recently appointed CEO and President Jon Serbousek commented on the quarter: “I joined Orthofix because I saw a significant opportunity. The last few months spent with this talented team and our external stakeholders has me even more excited about the future of this company.”
More articles on surgery centers:
California ASC could drop contract with Anthem over proposed rate decrease: 6 details
North Carolina legislators consider easing certificate-of-need laws for ASCs — 4 insights
Tenet-owned surgical hospital to pay $1.4M to settle False Claims Act allegations
